Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NCT05684016 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

George Washington University